Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Is the risk of serious infections increased in patients with RA who receive treatment with antirheumatic drugs?

Nature Clinical Practice Rheumatology volume 4, pages 16–17 (2008)Cite this article

boxed-textBernatsky S et al. (2007) Anti-rheumatic drug use and risk of serious infections in rheumatoid arthritis. Rheumatology 46: 1157–1160

Patients treated with anti-TNF agents are at a modestly increased risk of serious infection; appropriate measures for prevention and early treatment of infections should be implemented by the practicing rheumatologist

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Bongartz T et al. (2006) Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infection and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials. JAMA 295: 2275–2285

    Article  CAS  Google Scholar 

  2. Dixon WG et al. (2006) Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy: results from the British Society for Rheumatology Biologics Register. Arthritis Rheum 54: 2368–2376

    Article  CAS  Google Scholar 

  3. Listing J et al. (2005) Infections in patients with rheumatoid arthritis treated with biologic agents. Arthritis Rheum 52: 3403–3412

    Article  CAS  Google Scholar 

  4. Dixon WG et al. (2007) Serious infection following anti-tumor necrosis factor alpha therapy in patients with rheumatoid arthritis: lessons from interpreting data from observational studies. Arthritis Rheum 56: 2896–2904

    Article  CAS  Google Scholar 

  5. Saketkoo LA and Espinoza LR (2006) Impact of biologic agents on infectious diseases. Infect Dis Clin N Am 20: 931–961

    Article  Google Scholar 

  6. Strangfeld A and Listing J (2006) Infections and musculoskeletal conditions: bacterial and opportunistic infections during anti-TNF therapy. Best Pract Res Clin Rheumatol 20: 1181–1195

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Jasmine Farsarakis, Associate Editor, Nature Clinical Practice.

Author information

Author notes

  1. EA File is Associate Staff in the Department of Rheumatic and Immunologic Disease at the Cleveland Clinic Foundation, Cleveland, OH, USA.

Authors and Affiliations

  1. TM File Jr is a Professor in the Infectious Disease section, Northeastern Ohio Universities College of Medicine, Rootstown, OH, USA.,

    Thomas M File Jr & Elizabeth A File

Authors
  1. Thomas M File Jr
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Elizabeth A File
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Thomas M File Jr.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

File, T., File, E. Is the risk of serious infections increased in patients with RA who receive treatment with antirheumatic drugs?. Nat Rev Rheumatol 4, 16–17 (2008). https://doi.org/10.1038/ncprheum0684

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncprheum0684

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing